| Literature DB >> 30392958 |
Marc O Johnson1, Melissa M Wolf2, Matthew Z Madden2, Gabriela Andrejeva2, Ayaka Sugiura2, Diana C Contreras2, Damian Maseda2, Maria V Liberti3, Katelyn Paz4, Rigel J Kishton5, Matthew E Johnson6, Aguirre A de Cubas7, Pingsheng Wu8, Gongbo Li9, Yongliang Zhang9, Dawn C Newcomb10, Andrew D Wells6, Nicholas P Restifo5, W Kimryn Rathmell11, Jason W Locasale3, Marco L Davila9, Bruce R Blazar4, Jeffrey C Rathmell12.
Abstract
Activated T cells differentiate into functional subsets with distinct metabolic programs. Glutaminase (GLS) converts glutamine to glutamate to support the tricarboxylic acid cycle and redox and epigenetic reactions. Here, we identify a key role for GLS in T cell activation and specification. Though GLS deficiency diminished initial T cell activation and proliferation and impaired differentiation of Th17 cells, loss of GLS also increased Tbet to promote differentiation and effector function of CD4 Th1 and CD8 CTL cells. This was associated with altered chromatin accessibility and gene expression, including decreased PIK3IP1 in Th1 cells that sensitized to IL-2-mediated mTORC1 signaling. In vivo, GLS null T cells failed to drive Th17-inflammatory diseases, and Th1 cells had initially elevated function but exhausted over time. Transient GLS inhibition, however, led to increased Th1 and CTL T cell numbers. Glutamine metabolism thus has distinct roles to promote Th17 but constrain Th1 and CTL effector cell differentiation.Entities:
Keywords: T cells; chromatin; glutaminase; glutamine; mTOR; metabolism
Mesh:
Substances:
Year: 2018 PMID: 30392958 PMCID: PMC6361668 DOI: 10.1016/j.cell.2018.10.001
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582